Prot #C-145-03: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145) for the Treatment of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Project: Research project

Project Details

Effective start/end date2/23/182/23/23


  • Chiltern International, Inc. (Prot #C-145-03)
  • Iovance Biotherapeutics, Inc. (Prot #C-145-03)